Loss of eyebrows (madarosis) after use of long-acting methylphenidate: case report

Basit Öğe Kaydı
dc.authorid0000-0001-5207-6240en_US
dc.authorid0000-0002-5951-7253en_US
dc.contributor.authorYektaş, Çiğdem
dc.contributor.authorSamurcu, Nuran Demir
dc.contributor.authorTufan, Ali Evren
dc.date.accessioned2021-06-23T19:45:38Z
dc.date.available2021-06-23T19:45:38Z
dc.date.issued2017
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractTo the Editors: “Madarosis” from the Greek root of “madao” (shedding) is a term in medical terminology used to define loss of eyebrows and/or eyelashes due to shedding. Madarosis can arise as a clinical sign of diverse local or systemic disorders with various etiologies. The medical causes of madarosis include infections of eye and related structures (eg, blepharitis), dermatological disorders (eg, telogen effluvium, dermatitis, psoriasis), systemic and endocrine disorders (eg, systemic lupus erythematosus, hyperthyroidism/hypothyroidism, hyperparathyroidism/hypoparathyroidism), nutritional deficiencies leading to protein and trace element deficits (eg, zinc, biotine, ferritin), infections (eg, lepra, syphilis, fungi, and various parasites), trichotillomania, local radiotherapy, chemotherapy, and some of the pharmaceuticals.1 Madarosis can be induced by diverse groups of pharmaceuticals, among which retinoids, heparine, antiepileptics, inhibitors of the angiotensin-converting enzyme, androgenes, miotics, anticoagulants, lithium, propranolol, bromocriptine, statins, and antithyroid agents are listed. Those may lead to shedding and loss of the eyelashes and eyebrows in the telogen phase.en_US
dc.identifier.doi10.1097/JCP.0000000000000713
dc.identifier.endpage486en_US
dc.identifier.issn0271-0749
dc.identifier.issn1533-712X
dc.identifier.issue4en_US
dc.identifier.pmid28475521en_US
dc.identifier.scopus2-s2.0-85024390157en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage485en_US
dc.identifier.urihttps://doi.org/10.1097/JCP.0000000000000713
dc.identifier.urihttps://hdl.handle.net/20.500.12491/9187
dc.identifier.volume37en_US
dc.identifier.wosWOS:000405329400026en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorTufan, Ali Evren
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofJournal Of Clinical Psychopharmacologyen_US
dc.relation.publicationcategoryOlgu Sunumu - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMethylphenidateen_US
dc.subjectLoss of Eyebrows
dc.subjectMadarosis
dc.titleLoss of eyebrows (madarosis) after use of long-acting methylphenidate: case reporten_US
dc.typeCase Reporten_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
cigdem-yektas.pdf
Boyut:
87.77 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu